Literature DB >> 25747600

Associations of IL-2 and IL-4 Expression and Polymorphisms With the Risks of Mycoplasma pneumoniae Infection and Asthma in Children.

Rong-Shan Wang1, Hong-Xing Jin1, Shi-Qiang Shang2, Xi-Yong Liu1, Shu-Jun Chen1, Zhi-Biao Jin1.   

Abstract

INTRODUCTION: Asthma is an inflammatory disorder of the airways and the symptoms of asthma could be exacerbated by Mycoplasma pneumoniae infection. Interleukin-2 and interleukin-4 have been implicated in immune and inflammatory reactions. We examined the associations of IL2 and IL4 polymorphisms and expression with the risks of asthma and M. pneumoniae infection in children.
METHODS: 392 asthmatic children and 849 controls were recruited into the study. Eight polymorphisms in IL2 and IL4 were genotyped with Sequenom MassARRAY platform. M. pneumoniae infection and copy number was determined with fluorescence PCR. IL-2 and IL-4 serum expression levels were determined by using ELISA.
RESULTS: We found a significant association of IL2 rs6534349 polymorphism with increased asthma risk (heterozygotes, P=.029; homozygous variants; P=.013) and of IL4 rs2227284 polymorphism with reduced asthma risk (heterozygotes, P=.026; homozygous variants; P=.001). Besides, the association of other polymorphisms, except rs2070874 polymorphism, became apparent when the asthmatic children were grouped according to GINA classification of asthma control and severity. In addition, IL-2 and IL-4 serum expression levels were significantly higher in M. pneumoniae negative (P=.038) and positive (P=.011) subjects respectively. This observation holds true among asthmatic patients (P=.016 for IL-2 and P=.042 for IL-4), but only the IL-4 observation remained correct among non-asthmatic controls (P=.032). We also observed that the rs6534349 GG genotype was significantly associated with increased odds of getting high load M. pneumoniae infection (P=.0376).
CONCLUSIONS: IL2 and IL4 could be important biomarkers for estimating the risks of asthma and M. pneumoniae infection in children.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Asma; Asthma; Children; Interleucina-2; Interleucina-4; Interleukin-2; Interleukin-4; Mycoplasma pneumoniae; Niños

Mesh:

Substances:

Year:  2015        PMID: 25747600     DOI: 10.1016/j.arbres.2014.11.004

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Genetic correlation of SOCS3 polymorphisms with infantile asthma: an evidence based on a case-control study.

Authors:  Ying Fang; Xiaoxia Ren; Zhanwei Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  [Levels of airway inflammatory mediators in peripheral blood in infants and young children with wheezing].

Authors:  Xiao-He Yu; Miao He; Xiang-Rong Zheng; Xia Wang; Jian Kuang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

3.  Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: a meta-analysis based on 24 publications.

Authors:  Danyal Imani; Mohammad Masoud Eslami; Gholamreza Anani-Sarab; Mansur Aliyu; Bahman Razi; Ramazan Rezaei
Journal:  BMC Med Genet       Date:  2020-11-23       Impact factor: 2.103

4.  Novel Functional eQTL-SNPs Associated With Susceptibility to Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yang Dong; Yanmin Gao; Cheng Luo; Nengshun Wu; Zhounan Cheng; Anni Qiu; Yan Zhou; Wendi Zhang; Minjie Chu; Qing Chang
Journal:  Front Public Health       Date:  2022-06-28

5.  Interleukin 4 gene polymorphism (-589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies.

Authors:  Ahmad Kousha; Armita Mahdavi Gorabi; Mehdi Forouzesh; Mojgan Hosseini; Markov Alexander; Danyal Imani; Bahman Razi; Mohammad Javad Mousavi; Saeed Aslani; Haleh Mikaeili
Journal:  BMC Immunol       Date:  2020-10-21       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.